Lithium Carbonate
Active substance: lithium carbonate
TABLET, EXTENDED RELEASE · LITHIUM CARBONATE 300 mg/1
United StatesActive
Marketing holder: Alembic Pharmaceuticals Limited
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- LITHIUM CARBONATE · 300 mg/1
Registration
- Registration number
- 46708-148
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 46708-148 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 46708-148 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 46708-148 · Verified 2026-10-09 · open in source